INHIBITION OF DESMETHYLIMIPRAMINE 2-HYDROXYLATION BY DRUGS IN HUMAN-LIVER MICROSOMES

被引:109
作者
VONBAHR, C
SPINA, E
BIRGERSSON, C
ERICSSON, O
GORANSSON, M
HENTHORN, T
SJOQVIST, F
机构
关键词
D O I
10.1016/0006-2952(85)90533-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:2501 / 2505
页数:5
相关论文
共 31 条
[2]  
ALVAN G, 1982, LANCET, V1, P333
[3]   ROLE OF OXIDATION POLYMORPHISM ON BLOOD AND URINE CONCENTRATIONS OF AMITRIPTYLINE AND ITS METABOLITES IN MAN [J].
BALANTGORGIA, AE ;
SCHULZ, P ;
DAYER, P ;
BALANT, L ;
KUBLI, A ;
GERTSCH, C ;
GARRONE, G .
ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1982, 232 (03) :215-222
[4]   THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE [J].
BERTILSSON, L ;
ABERGWISTEDT, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :388-390
[5]  
BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[6]   THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM [J].
DAHLQVIST, R ;
BERTILSSON, L ;
BIRKETT, DJ ;
EICHELBAUM, M ;
SAWE, J ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :815-821
[7]   EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].
DAVIES, DS ;
KAHN, GC ;
MURRAY, S ;
BRODIE, MJ ;
BOOBIS, AR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91
[8]   THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171
[9]   ANTIPYRINE METABOLISM IN RELATION TO POLYMORPHIC OXIDATIONS OF SPARTEINE AND DEBRISOQUINE [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :317-321
[10]   POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J ;
ZEKORN, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186